Green Cross Health
Market Cap
NZ$144.6m
Last Updated
2020/09/17 19:05 UTC
Data Sources
Company Financials
Executive Summary
Green Cross Health Limited provides health support, care, and advice services to communities in New Zealand. More Details
Rewards
Risk Analysis
Snowflake Analysis
Undervalued with mediocre balance sheet.
Share Price & News
How has Green Cross Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: GXH has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
0%
GXH
-0.6%
NZ Consumer Retailing
-0.6%
NZ Market
1 Year Return
-8.2%
GXH
1.4%
NZ Consumer Retailing
3.1%
NZ Market
Return vs Industry: GXH underperformed the NZ Consumer Retailing industry which returned 2.8% over the past year.
Return vs Market: GXH underperformed the NZ Market which returned 3.5% over the past year.
Shareholder returns
| GXH | Industry | Market | |
|---|---|---|---|
| 7 Day | 0% | -0.6% | -0.6% |
| 30 Day | -2.9% | -8.6% | 0.5% |
| 90 Day | -1.0% | 0.8% | 4.2% |
| 1 Year | -5.0%-8.2% | 5.7%1.4% | 7.6%3.1% |
| 3 Year | -45.9%-53.7% | 36.0%26.8% | 44.4%24.5% |
| 5 Year | -42.8%-54.1% | 52.5%35.4% | 98.8%48.9% |
Price Volatility Vs. Market
How volatile is Green Cross Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 days ago | Simply Wall St
Green Cross Health Limited's (NZSE:GXH) Price Is Right But Growth Is Lacking3 weeks ago | Simply Wall St
Would Shareholders Who Purchased Green Cross Health's(NZSE:GXH) Stock Five Years Be Happy With The Share price Today?1 month ago | Simply Wall St
We Think Green Cross Health's (NZSE:GXH) Statutory Profit Might Understate Its Earnings PotentialValuation
Is Green Cross Health undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: GXH (NZ$1.01) is trading below our estimate of fair value (NZ$12.21)
Significantly Below Fair Value: GXH is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: GXH is good value based on its PE Ratio (10.7x) compared to the XX Consumer Retailing industry average (20.9x).
PE vs Market: GXH is good value based on its PE Ratio (10.7x) compared to the NZ market (22.2x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate GXH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: GXH is good value based on its PB Ratio (1.2x) compared to the XO Consumer Retailing industry average (2.1x).
Next Steps
Future Growth
How is Green Cross Health forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
10.5%
Forecasted Consumer Retailing industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Green Cross Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Examine whether Green Cross Health is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Green Cross Health competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Consumer Retailing industry.
Past Performance
How has Green Cross Health performed over the past 5 years?
-2.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GXH has high quality earnings.
Growing Profit Margin: GXH's current net profit margins (2.4%) are lower than last year (2.8%).
Past Earnings Growth Analysis
Earnings Trend: GXH's earnings have declined by 2.8% per year over the past 5 years.
Accelerating Growth: GXH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: GXH had negative earnings growth (-16.2%) over the past year, making it difficult to compare to the Consumer Retailing industry average (11.3%).
Return on Equity
High ROE: GXH's Return on Equity (12.6%) is considered low.
Next Steps
Financial Health
How is Green Cross Health's financial position?
Financial Position Analysis
Short Term Liabilities: GXH's short term assets (NZ$111.7M) exceed its short term liabilities (NZ$108.9M).
Long Term Liabilities: GXH's short term assets (NZ$111.7M) do not cover its long term liabilities (NZ$133.0M).
Debt to Equity History and Analysis
Debt Level: GXH's debt to equity ratio (41.9%) is considered high.
Reducing Debt: GXH's debt to equity ratio has increased from 39.8% to 41.9% over the past 5 years.
Debt Coverage: GXH's debt is well covered by operating cash flow (96.2%).
Interest Coverage: GXH's interest payments on its debt are well covered by EBIT (4.7x coverage).
Balance Sheet
Next Steps
Dividend
What is Green Cross Health current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate GXH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate GXH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if GXH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if GXH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: GXH is not paying a notable dividend for the NZ market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of GXH's dividend in 3 years as they are not forecast to pay a notable one for the NZ market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.1yrs
Average management tenure
CEO
Rachael Newfield
1.67yrs
Tenure
Ms. Rachael Newfield has been the Group Chief Executive Officer of Green Cross Health Limited since January 2019.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Group Chief Executive Officer | 1.67yrs | no data | no data | |
| Group CFO & Company Secretary | 0.92yr | no data | no data | |
| Chief Information Officer | 2.5yrs | no data | no data | |
| Chief Executive Officer of Pharmacy & Medical | 6.92yrs | no data | 0.50% NZ$ 717.9k | |
| Chief Executive Officer of Community Health Division | no data | no data | no data |
2.1yrs
Average Tenure
Experienced Management: GXH's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman | 0.75yr | NZ$40.00k | no data | |
| Non-Executive Director | 11yrs | NZ$77.92k | no data | |
| Non-Executive Director | 11.08yrs | NZ$35.00k | no data | |
| Non-Executive Director | 11.08yrs | NZ$35.00k | 32.09% NZ$ 46.4m | |
| Independent Director | 8.5yrs | NZ$70.00k | no data | |
| Non-Executive Director | 3.33yrs | NZ$35.00k | no data | |
| Independent Director | 3.25yrs | NZ$70.00k | 0.035% NZ$ 50.5k |
8.5yrs
Average Tenure
Experienced Board: GXH's board of directors are considered experienced (8.5 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Green Cross Health Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Green Cross Health Limited
- Ticker: GXH
- Exchange: NZSE
- Founded: 1999
- Industry: Drug Retail
- Sector: Consumer Retailing
- Market Cap: NZ$144.584m
- Shares outstanding: 143.15m
- Website: https://www.greencrosshealth.co.nz
Number of Employees
Location
- Green Cross Health Limited
- Building B
- Ground Floor
- Auckland
- 1051
- New Zealand
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| GXH | NZSE (New Zealand Stock Exchange) | Yes | Ordinary Shares | NZ | NZD | Oct 2009 |
| PRCX.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | Oct 2009 |
Biography
Green Cross Health Limited provides health support, care, and advice services to communities in New Zealand. It operates in three segments: Pharmacy Services, Medical Services, and Community Health. The Ph ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/09/17 19:05 |
| End of Day Share Price | 2020/09/17 00:00 |
| Earnings | 2020/03/31 |
| Annual Earnings | 2020/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.